Editors' corner: Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach

被引:36
作者
Zanchetti, A
Mancia, G
机构
关键词
D O I
10.1097/00004872-199607000-00001
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:809 / 811
页数:3
相关论文
共 13 条
[1]  
FROHLICH ED, 1996, IN PRESS HYPERTENSIO
[2]   THE COST-EFFECTIVENESS OF HYPERTENSION TREATMENT IN SWEDEN [J].
JOHANNESSON, M .
PHARMACOECONOMICS, 1995, 7 (03) :242-250
[3]   Guidelines for antihypertensive therapy [J].
MacMahon, S .
JOURNAL OF HYPERTENSION, 1996, 14 (06) :691-693
[4]  
MANCIA G, 1996, IN PRESS J HYPERTE S, V14
[5]  
*METR LIF INS CO, 1961, BLOOD PRESS INS EXP
[6]   Guidelines for antihypertensive therapy: Problems with a strategy based on absolute cardiovascular risk [J].
Simpson, FO .
JOURNAL OF HYPERTENSION, 1996, 14 (06) :683-689
[7]  
Swales JD, 1995, J HYPERTENS, V13, P1357
[8]   Treating hypertension [J].
Swales, JD .
JOURNAL OF HYPERTENSION, 1996, 14 (07) :813-814
[9]   Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality - The framingham heart study 1950 to 1990 [J].
Sytkowski, PA ;
DAgostino, RB ;
Belanger, AJ ;
Kannel, WB .
CIRCULATION, 1996, 93 (04) :697-703
[10]  
Zanchetti A, 1995, J HYPERTENS, V13, P1522